ENLIVEN THERAPEUTICS, INC. Interest Income (Expense), Nonoperating, Net
ENLIVEN THERAPEUTICS, INC. (ELVN) reported Interest Income (Expense), Nonoperating, Net of $4.73 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-08-05
- ENLIVEN THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was $4.73M, a 45.56% increase year-over-year.
- ENLIVEN THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2026-03-31 was $4.20M, a 31.29% increase year-over-year.
- ENLIVEN THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2025-12-31 was $4.62M, a 24.27% increase year-over-year.
- ENLIVEN THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was $4.95M, a 28.89% increase year-over-year.
- ENLIVEN THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2025 was $16.01M, a 7.53% increase from fiscal 2024.
- ENLIVEN THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2024 was $14.89M, a 24.43% increase from fiscal 2023.
- ENLIVEN THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2023 was $11.97M, a 959.96% increase from fiscal 2022.
- ENLIVEN THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2022 was $1.13M.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 3 month as first filed | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 6 month as first filed | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 9 month as first filed | Interest Income (Expense), Nonoperating, Net 12 month | Interest Income (Expense), Nonoperating, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.73M 10-Q · filed 2026-08-05 | $8.93M 10-Q · filed 2026-08-05 | $13.55M derived: sum of 3 quarters · filed 2026-08-05 | $18.49M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $4.20M 10-Q · filed 2026-05-07 | $8.81M derived: sum of 2 quarters · filed 2026-05-07 | $13.76M derived: sum of 3 quarters · filed 2026-05-07 | $17.01M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $9.57M derived: sum of 2 quarters · filed 2026-03-03 | $12.82M derived: sum of 3 quarters · filed 2026-08-05 | $16.01M 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | $4.95M 10-Q · filed 2025-11-12 | $8.20M derived: sum of 2 quarters · filed 2026-08-05 | $11.39M 10-Q · filed 2025-11-12 | $15.11M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $3.25M 10-Q · filed 2026-08-05 | $6.45M 10-Q · filed 2026-08-05 | $10.16M derived: sum of 3 quarters · filed 2026-08-05 | $14.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $3.20M 10-Q · filed 2026-05-07 | $6.91M derived: sum of 2 quarters · filed 2026-05-07 | $10.75M derived: sum of 3 quarters · filed 2026-05-07 | $14.84M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $3.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $7.55M derived: sum of 2 quarters · filed 2026-03-03 | $11.64M derived: sum of 3 quarters · filed 2026-03-03 | $14.89M 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | $3.84M 10-Q · filed 2025-11-12 | $7.92M derived: sum of 2 quarters · filed 2025-11-12 | $11.18M 10-Q · filed 2025-11-12 | $14.54M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $4.09M 10-Q · filed 2025-08-13 | $7.34M 10-Q · filed 2025-08-13 | $10.70M derived: sum of 3 quarters · filed 2025-08-13 | $14.20M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $3.25M 10-Q · filed 2025-05-14 | $6.62M derived: sum of 2 quarters · filed 2025-05-14 | $10.11M derived: sum of 3 quarters · filed 2025-05-14 | $13.52M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $3.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $6.86M derived: sum of 2 quarters · filed 2025-03-13 | $10.27M derived: sum of 3 quarters · filed 2025-03-13 | $11.97M 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | $3.49M 10-Q · filed 2024-11-13 | $6.91M derived: sum of 2 quarters · filed 2024-11-13 | $8.60M 10-Q · filed 2024-11-13 | $9.21M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $3.41M 10-Q · filed 2024-08-13 | $5.11M 10-Q · filed 2024-08-13 | $5.72M derived: sum of 3 quarters · filed 2024-08-13 | $6.10M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $1.69M 10-Q · filed 2024-05-14 | $2.31M derived: sum of 2 quarters · filed 2024-05-14 | $2.69M derived: sum of 3 quarters · filed 2024-05-14 | $2.81M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $613.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $993.00K derived: sum of 2 quarters · filed 2024-03-14 | $1.12M derived: sum of 3 quarters · filed 2024-03-14 | $1.13M 10-K · filed 2024-03-14 | $943.00K 10-K · filed 2023-02-10 | |||
| 2022-09-30 | $380.00K 10-Q · filed 2023-11-09 | $242.00K 10-Q · filed 2022-10-25 | $507.00K derived: sum of 2 quarters · filed 2023-11-09 | $516.00K 10-Q · filed 2023-11-09 | $430.00K 10-Q · filed 2022-10-25 | $377.00K derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $127.00K 10-Q · filed 2023-08-10 | $110.00K 10-Q · filed 2022-08-03 | $136.00K 10-Q · filed 2023-08-10 | $188.00K 10-Q · filed 2022-08-03 | -$3.00K derived: sum of 3 quarters · filed 2023-08-10 | $27.00K derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $9.00K 10-Q · filed 2023-05-11 | $78.00K 10-Q · filed 2022-05-06 | -$130.00K derived: sum of 2 quarters · filed 2023-06-23 | -$100.00K derived: sum of 3 quarters · filed 2023-06-23 | -$52.00K derived: sum of 4 quarters · filed 2023-06-23 | |||
| 2021-12-31 | -$139.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-06-23 | -$109.00K derived: sum of 2 quarters · filed 2023-06-23 | -$61.00K derived: sum of 3 quarters · filed 2023-06-23 | $22.00K 8-K · filed 2023-06-23 | $233.00K 10-K · filed 2022-03-15 | |||
| 2021-09-30 | $30.00K 10-Q · filed 2022-10-25 | $78.00K derived: sum of 2 quarters · filed 2022-10-25 | $161.00K 10-Q · filed 2022-10-25 | $276.00K derived: sum of 4 quarters · filed 2022-10-25 | ||||
| 2021-06-30 | $48.00K 10-Q · filed 2022-08-03 | $131.00K 10-Q · filed 2022-08-03 | $246.00K derived: sum of 3 quarters · filed 2022-08-03 | $372.00K derived: sum of 4 quarters · filed 2022-08-03 | ||||
| 2021-03-31 | $83.00K 10-Q · filed 2022-05-06 | $198.00K derived: sum of 2 quarters · filed 2022-05-06 | $324.00K derived: sum of 3 quarters · filed 2022-05-06 | $434.00K derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $241.00K derived: sum of 2 quarters · filed 2022-03-15 | $351.00K derived: sum of 3 quarters · filed 2022-03-15 | $483.00K 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $126.00K 10-Q · filed 2021-11-09 | $236.00K derived: sum of 2 quarters · filed 2021-11-09 | $368.00K 10-Q · filed 2021-11-09 | $532.00K derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | $110.00K 10-Q · filed 2021-08-06 | $242.00K 10-Q · filed 2021-08-06 | $406.00K derived: sum of 3 quarters · filed 2021-08-06 | $660.00K derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2020-03-31 | $132.00K 10-Q · filed 2021-05-11 | $296.00K derived: sum of 2 quarters · filed 2021-05-11 | $550.00K derived: sum of 3 quarters · filed 2021-05-11 | $710.00K derived: sum of 4 quarters · filed 2021-05-11 | ||||
| 2019-12-31 | $164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $418.00K derived: sum of 2 quarters · filed 2021-03-05 | $578.00K derived: sum of 3 quarters · filed 2021-03-05 | $578.00K 10-K · filed 2021-03-05 | ||||
| 2019-09-30 | $254.00K 10-Q · filed 2020-11-05 | $414.00K derived: sum of 2 quarters · filed 2020-11-05 | $414.00K 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $160.00K 10-Q · filed 2020-08-14 | $160.00K 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |